Showing results 11670 to 11689 of 14621
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2023 | S. aureus biofilm metabolic activity correlates positively with patients’ eosinophil frequencies and disease severity in chronic rhinosinusitis | Shaghayegh, G.; Cooksley, C.; Bouras, G.; Houtak, G.; Nepal, R.; Psaltis, A.J.; Wormald, P.-J.; Vreugde, S. |
| 2007 | S100A8/S100A9 and their association with cartilage and bone | Zreiqat, H.; Howlett, C.; Gronthos, S.; Hume, D.; Geczy, C. |
| 2016 | Safe management of expressed breast milk: a systematic review | Peters, M.; McArthur, A.; Munn, Z. |
| 2023 | Safeguarding youth sexual and reproductive health and rights in the context of increasing climate-related disasters in the Pacific: A scoping review of policies and responses | Murphy, N.; Azzopardi, P.; Bohren, M.A. |
| 2012 | Safety and acceptability of suprascapular nerve block in rheumatology patients | Shanahan, E.; Shanahan, K.; Hill, C.; Ahern, M.; Smith, M. |
| 2023 | Safety and Adverse Events following Non-invasive Electrical Brain Stimulation in Stroke: A Systematic Review | Turnbull, C.; Boomsma, A.; Milte, R.; Stanton, T.R.; Hordacre, B. |
| 2013 | Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: The EnligHTN I trial | Worthley, S.; Tsioufis, C.; Worthley, M.; Sinhal, A.; Chew, D.; Meredith, I.; Malaiapan, Y.; Papademetriou, V. |
| 2020 | Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial | Hankey, G.J.; Hackett, M.L.; Almeida, O.P.; Flicker, L.; Mead, G.E.; Dennis, M.S.; Etherton-Beer, C.; Ford, A.H.; Billot, L.; Jan, S.; Lung, T.; Murray, V.; Lundström, E.; Anderson, C.S.; Herbert, R.; Carter, G.; Donnan, G.A.; Nguyen, H.T.; Gommans, J.; Yi, Q.; et al. |
| 2013 | Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study | Ross, D.; Branford, S.; Seymour, J.; Schwarer, A.; Arthur, C.; Yeung, D.; Dang, P.; Goyne, J.; Slader, C.; Filshie, R.; Mills, A.; Vaz de Melo, J.; White, D.; Grigg, A.; Hughes, T. |
| 2020 | Safety and efficacy of laxatives after major abdominal surgery: systematic review and meta-analysis | Dudi-Venkata, N.; Seow, W.; Kroon, H.M.; Bedrikovetski, S.; Moore, J.W.; Thomas, M.L.; Sammour, T. |
| 2014 | Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis | Cheema, B.; Kilbreath, S.; Fahey, P.; Delaney, G.; Atlantis, E. |
| 2023 | Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial | Fehlings, M.G.; Moghaddamjou, A.; Harrop, J.S.; Stanford, R.; Ball, J.; Aarabi, B.; Freeman, B.J.C.; Arnold, P.M.; Guest, J.D.; Kurpad, S.N.; Schuster, J.M.; Nassr, A.; Schmitt, K.M.; Wilson, J.R.; Brodke, D.S.; Ahmad, F.U.; Yee, A.; Ray, W.Z.; Brooks, N.P.; Wilson, J.; et al. |
| 2014 | Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily | Hughes, T.; Hochhaus, A.; Kantarjian, H.; Cervantes, F.; Guilhot, F.; Niederwieser, D.; Le Coutre, P.; Rosti, G.; Ossenkoppele, G.; Lobo, C.; Shibayama, H.; Fan, X.; Menssen, H.; Kemp, C.; Larson, R.; Saglio, G. |
| 2023 | Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post-Hoc Analysis of the EXTEND-IA TNK Trials | Yogendrakumar, V.; Churilov, L.; Mitchell, P.J.; Kleinig, T.J.; Yassi, N.; Thijs, V.; Wu, T.; Shah, D.; Bailey, P.; Dewey, H.M.; Choi, P.M.; Ma, A.; Wijeratne, T.; Garcia-Esperon, C.; Cloud, G.; Chandra, R.V.; Cordato, D.J.; Yan DMedSc, B.; Sharma, G.; Desmond, P.M.; et al. |
| 2014 | Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis | Drilling, A.; Morales, S.; Boase, S.; Jervis-Bardy, J.; James, C.; Jardeleza, C.; Tan, N.; Cleland, E.; Speck, P.; Vreugde, S.; Wormald, P. |
| 2022 | Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies. | Marshall, H.S.; Vesikari, T.; Richmond, P.C.; Wysocki, J.; Szenborn, L.; Beeslaar, J.; Maguire, J.D.; Balmer, P.; O'Neill, R.; Anderson, A.S.; Prégaldien, J.-L.; Maansson, R.; Jiang, H.-Q.; Perez, J.L. |
| 2019 | Safety and immunogenicity of MF59-adjuvanted cell culture-derived A/H5N1 subunit influenza virus vaccine: dose-finding clinical trials in adults and the elderly | Frey, S.E.; Shakib, S.; Chanthavanich, P.; Richmond, P.; Smith, T.; Tantawichien, T.; Kittel, C.; Jaehnig, P.; Mojares, Z.; Verma, B.; Kanesa-Thasan, N.; Hohenboken, M. |
| 2011 | Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study | Kotasek, D.; Tebbutt, N.; Desai, J.; Welch, S.; Siu, L.; McCoy, S.; Sun, Y.; Johnson, J.; Adewoye, A.; Price, T. |
| 2008 | Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours | Price, T.; Lipton, L.; McGreivy, J.; McCoy, S.; Sun, Y.; Rosenthal, M. |
| 2020 | Safety and protective effects of maternal influenza vaccination on pregnancy and birth outcomes: A prospective cohort study | Mohammed, H.; Roberts, C.T.; Grzeskowiak, L.E.; Giles, L.C.; Dekker, G.A.; Marshall, H.S. |
